{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:29:11Z","timestamp":1759742951886},"reference-count":15,"publisher":"FapUNIFESP (SciELO)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"abstract":"<jats:p>ABSTRACT The study reviewed the histology of cases of grade I meningiomas with spontaneous necrosis, grade I without necrosis and grade II meningiomas, to evaluate the histological and immunohistochemical factors of the patients\u2019 prognosis, while correlating the clinicopathological features with the clinical follow-up of the patients. A review of 47 cases from the Department of Pathology of UNIFESP was performed and the samples were submitted to immunohistochemical examination with the p53 protein, Ki-67 cell proliferation factor and progesterone receptor markers. A greater expression was found in the progression of several degrees of aggressiveness for p53 and Ki-67, and a higher frequency of progesterone receptors in the lower degrees. The group of grade I meningiomas with spontaneous necrosis showed histological and immunohistochemical indexes that approximate those of the grade II meningioma. This suggests a worse prognosis for grade I meningiomas with necrosis.<\/jats:p>","DOI":"10.1590\/0004-282x20180121","type":"journal-article","created":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T18:39:07Z","timestamp":1544899147000},"page":"756-759","source":"Crossref","is-referenced-by-count":2,"title":["Grade I meningiomas with atypical characteristics: a worse prognosis"],"prefix":"10.1590","volume":"76","author":[{"given":"D\u00e9bora S.","family":"Marcos","sequence":"first","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoel A.","family":"Paiva Neto","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"G\u00f3es","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celina T. F.","family":"Oshima","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo S.","family":"Silva","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o N.","family":"St\u00e1vale","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2018,11]]},"reference":[{"key":"ref1","series-title":"WHO classification of tumours of the central nervous system","author":"Louis DN","year":"2016","edition":"4th edition"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1227\/NEU.0000000000000462","article-title":"Management of atypical cranial meningiomas. Part 2: predictors of progression and the role of adjuvant radiation after subtotal resection","volume":"75","author":"Sun SQ","year":"2014","journal-title":"Neurosurgery"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/HP.S93413","article-title":"The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy","volume":"3","author":"Muz B","year":"2015","journal-title":"Hypoxia (Auckl)"},{"key":"ref4","series-title":"Astrocytic and oligodendroglial tumors","first-page":"98","volume-title":"Practical surgical neuropathology","author":"Perry A","year":"2010","edition":"2nd edition"},{"issue":"3","key":"ref5","first-page":"142","article-title":"Expression of progestrone receptor and proliferative marker ki 67 in various grades of meningioma","volume":"48","author":"Shayanfar N","year":"2010","journal-title":"Acta Med Iran"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00701-003-0173-4","article-title":"The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases","volume":"146","author":"Roser F","year":"2004","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/humu.10172","article-title":"TP53 family members and human cancers","volume":"21","author":"B\u00e9nard J","year":"2003","journal-title":"Hum Mutat"},{"issue":"3","key":"ref8","first-page":"231","article-title":"The histopathological spectrum of human meningiomas","volume":"5","author":"Backer-Gr\u00f8ndahl T","year":"2012","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4149\/neo_2013_062","article-title":"Expression of Ki-67 and p53 in meningiomas","volume":"60","author":"Pavelin S","year":"2013","journal-title":"Neoplasma"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-014-1620-1","article-title":"Atypical meningoma: current management dilemmas and prospective clinical trials","volume":"121","author":"Jenkinson MD","year":"2015","journal-title":"J Neurooncol"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/apm.12248","article-title":"Histopathology and prognosis in human meningiomas","volume":"122","author":"Backer-Gr\u00f8ndahl T","year":"2014","journal-title":"APMIS"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3346\/jkms.1999.14.2.199","article-title":"Role of p53 gene mutation in tumor aggressiveness of intracranial meningiomas","volume":"14","author":"Cho H","year":"1999","journal-title":"J Korean Med Sci"},{"issue":"1","key":"ref13","first-page":"EC15","article-title":"Histopathological and immunohistochemical evaluation of meningiomas with reference to proliferative markers p53 and Ki-67","volume":"10","author":"Telugu RB","year":"2016","journal-title":"J Clin Diagn Res"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3923\/pjbs.2012.530.535","article-title":"Status of Ki-67, estrogen and progesterone receptors in various subtypes of intracranial meningiomas","volume":"15","author":"Fakhrjou A","year":"2012","journal-title":"Pak J Biol Sci"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4103\/0028-3886.141248","article-title":"Evaluation of 1p and 14q status, MIB-1 labeling index and progesterone receptor immunoexpression in meningiomas: adjuncts to histopathological grading and predictors of aggressive behavior","volume":"62","author":"Kumar S","year":"2014","journal-title":"Neurol India"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"deposited":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T18:04:07Z","timestamp":1545501847000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2018001100756&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":15,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11]]}},"alternative-id":["S0004-282X2018001100756"],"URL":"https:\/\/doi.org\/10.1590\/0004-282x20180121","relation":{},"ISSN":["1678-4227","0004-282X"],"issn-type":[{"value":"1678-4227","type":"electronic"},{"value":"0004-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}